Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations

Journal of Clinical Pathology

Volumn 52, Issue 5, 1999, Pages 372-375

  Zweemer, R P ^b   Shaw, P A ^f   Verheijen, R M H ^b   Ryan, A ^a   Berchuck, A ^c   Ponder, B A J ^d   Risch, H ^e   McLaughlin, J R ^f   Narod, S A ^f   Menko, F H ^b   Kenemans, P ^b   Jacobs, I J ^a  

^a Gynaecology Cancer Research Unit   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UKCCCR Familial Ovarian Cancer R   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE

Author keywords

BRCA1 and BRCA2; Hereditary ovarian cancer; Immunohistochemistry; P53

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0012277621     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.5.372     Document Type: Article

References (18)

1. 1 Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. 2 Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378: 789-92.
3. 3 Ford D, Easton DF, Stratton M, et al, and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62:676-89.
4. 4 Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56: 265-71.
5. 5 Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120-8.
6. 6 Berchuck A, Kohler MF, Marks JR, et al. The p53 tumour suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 1994;170:246-52.
7. 7 Kupryjanczyk J, Thor AD, Beauchamp R, et al. p53 Gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 1993;90:4961-5.
8. 8 Kohler MF, Marks JR, Wiseman RW, et al. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 1993;85:1513-19.
9. 9 Kerns BJ, Jordan PA, Moore MB, et al. p53 Overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. J Histochem Cytochem 1992;40: 1047-51.
10. 10 Benda J, Zaino R, eds. Gynecological Oncology Group pathology manual, 1994: http://www.vh.org/Providers/Textbooks/ OBGYNOncology/PathologyManualHome.html
11. 11 Crook T, Crossland S, Crompton MR, et al. p53 Mutations in BRCA1-associated familial breast cancer [letter]. Lancet 1997;30:638-9.
12. 12 Auranen A, Grenman S, Klemi P-J. Immunohistochemically detected p53 and her-2/neu expression and nuclear DNA content in familial epithelial ovarian carcinomas. Cancer 1997;79:2147-53.
13. 13 Casey G, Lopez ME, Ramos JC, et al. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 1996;13:1971-81.
14. 14 Skilling JS, Sood A, Niemann T, et al. An abundance of p53 null mutations in ovarian carcinoma. Oncogene 1996;13: 117-23.
15. 15 Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
16. 16 Stratton JF, Gayther SA, Russell P, et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997; 336:1125-30.
17. 17 Zweemer RP, Verheijen RHM, Gille JJP, et al. Clinical and genetic evaluation of 30 ovarian cancer families. Am J Obstet Gynecol 1998;178:85-90
18. 18 Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 1996;335: 1413-6.